Abliva AB

0.0280

0.0000

Volume:- -

Turnover:- -

Market Cap:45.14M

PE:-4.43

High:0.0280

Open:0.0280

Low:0.0280

Close:0.0280

52wk High:0.0374

52wk Low:0.0280

Shares:1.61B

Float Shares:873.79M

Volume Ratio:1.70

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0063

EPS(LYR):-0.0060

ROE:-135.88%

ROA:-71.03%

PB:6.87

PE(LYR):-4.66

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Pharming Group NV Publishes Transcript of Q3 2025 Financial Results Call

Reuters

·

Nov 11

Pharming Group NV Addresses Shareholders' Queries Ahead of AGM: Discusses Acquisition of Abliva, U.S. Market Focus, and Future Prospects

Reuters

·

Sep 08

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NEVPF"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NEVPF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NEVPF\",,,,,undefined,":{"symbol":"NEVPF","market":"US","secType":"STK","nameCN":"Abliva AB","latestPrice":0.028,"timestamp":1764968400000,"preClose":0.028,"halted":0,"volume":0,"delay":15,"floatShares":873789550,"shares":1612000000,"eps":-0.006325,"marketStatus":"Not Yet Opened","change":0,"latestTime":"12-05 16:00:00 EST Delay","open":0.028,"high":0.028,"low":0.028,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.006325,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.028,"volumeRatio":1.699855696912227},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NEVPF\",,,,,undefined,":{"symbol":"NEVPF","floatShares":873789550,"roa":"-71.03%","roe":"-135.88%","lyrEps":-0.006015,"volumeRatio":1.699855696912227,"shares":1612000000,"dividePrice":0,"high":0.028,"amplitude":0,"preClose":0.028,"low":0.028,"week52Low":0.028,"pbRate":"6.87","psRate":"852.91","week52High":0.0374,"institutionHeld":0,"latestPrice":0.028,"eps":-0.006325,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.006325,"open":0.028,"prevYearClose":0.036,"prevWeekClose":0.028,"prevMonthClose":0.028,"prevQuarterClose":0.028,"fiveDayClose":0.028,"twentyDayClose":0.028,"sixtyDayClose":0.028},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NEVPF\",params:#limit:5,,,undefined,":[{"date":"2024-05-23","symbol":"NEVPF","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1716451200000,"name":null,"time":"","dateTimestamp":1716436800000,"actualEps":null},{"market":"US","date":"2024-02-23","symbol":"NEVPF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1708664400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-11-17","symbol":"NEVPF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1700197200000,"reportTimeType":"","actualEps":null},{"date":"2023-08-18","symbol":"NEVPF","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692345600000,"name":null,"time":"","dateTimestamp":1692331200000,"actualEps":null},{"date":"2022-08-19","symbol":"NEVPF","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1660896000000,"name":null,"time":"","dateTimestamp":1660881600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NEVPF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NEVPF\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NEVPF\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2582350808","title":"Pharming Group NV Publishes Transcript of Q3 2025 Financial Results Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2582350808","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582350808?lang=en_us&edition=fundamental","pubTime":"2025-11-11 18:27","pubTimestamp":1762856822,"startTime":"0","endTime":"0","summary":"Pharming Group NV has published the transcript of its Q3 2025 earnings call, which took place on November 6, 2025. The event was attended by key members of Pharming's management team, including the Chief Executive Officer, Chief Commercial Officer, Chief Medical Officer, and Chief Financial Officer, as well as analysts from major financial institutions. During the call, management reported strong financial results, highlighting a 30% year-over-year revenue growth for the third quarter and an operating profit of US$15.8 million-nearly four times higher than the previous year. Additionally, operating cash flow reached US$32 million, nearly restoring the company's cash position to pre-acquisition levels following the purchase of Abliva. Looking ahead, management emphasized the rapid progress of Pharming's product pipeline: \"Our high-value pipeline is advancing rapidly, with a clear objective to deliver two potential blockbuster assets, creating meaningful value creation catalyst for share","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDL9PCcHs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NEVPF"],"gpt_icon":0},{"id":"2565681611","title":"Pharming Group NV Addresses Shareholders' Queries Ahead of AGM: Discusses Acquisition of Abliva, U.S. Market Focus, and Future Prospects","url":"https://stock-news.laohu8.com/highlight/detail?id=2565681611","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565681611?lang=en_us&edition=fundamental","pubTime":"2025-09-08 20:34","pubTimestamp":1757334887,"startTime":"0","endTime":"0","summary":"Pharming Group NV Addresses Shareholders' Queries Ahead of AGM: Discusses Acquisition of Abliva, U.S. Market Focus, and Future Prospects. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharming Group NV published the original content used to generate this news brief on September 08, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nNDL9dnNth:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEVPF","BK4139"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NEVPF\",params:#limit:6,delay:false,,,undefined,":[]}}